With human health as its mission, Maple Pharmtech is committed to providing global customers with high-quality pharmaceutical products, continuously improving the quality of life of the public.

Maple Pharmtech was founded by a group of like-minded senior professionals in the healthcare industry in Aug. 2012. The whole team has many years of pharmaceutical industry background and strong technological advantages in chemical synthesis and generic and innovative drug development, and has extensive experience in business management.

With headquarter in Shenzhen, Maple Pharmtech has a comprehensive R&D center located in Jiangsu province as well as several cooperative cGMP manufacturing sites in Hunan, Anhui, Jiangxi Province & Chongqing City. Maple Pharmtech has well-developed research and development system, strict quality assurance & quality control system and cGMP manufacturing sites complying with the requirements of ICH Q7.

Maple Pharmtech has formed innovative drug and generic drug pipelines mainly focusing on anti-hyperglycemic, anti-cancer, anti-infective, hormone areas,etc. There are dozens featured generic & innovative drug projects under manufacturing in the cooperative sites. 

Maple Pharmtech has a powerful team of pharmaceutical research and development experts, till now the company has accumulatively applied 29 domestic and international patents.

As a qualified corporate citizen, we believe that corporate development and social responsibility should be balanced. We are committed to making sustained efforts for environmental and social sustainability.

We believe that with the joint efforts of Maple Pharmtech and our customers & partners, we together will contribute to the alleviation of human pain, and the improvement of human health by providing more high-quality, safe & effective APIs and high-quality health services. 

Innovation & R&D is our core competence. Through continuous innovation & R&D, Maple Pharmtech aims to be a pioneer in the innovative pharmaceutical industry in China.